The aims of our research are twofold: (1) to discover blood biomarkers for oesophageal and prostate cancer, and to translate these into diagnostic tests and (2) to discover novel therapeutic targets for drug development.
Dr Hill received her PhD from The University of Queensland in 2000, working with Professor David James on insulin signalling. She undertook two post-doctoral positions: firstly with Dr Brian Hemmings on Akt regulation in Switzerland, then with Professor Seamus Martin on apoptosomes in Ireland. Dr Hill returned to the UQ Institute for Molecular Bioscience in 2004, working with Professors John Hancock and Rob Parton on membrane microdomains. In 2009, Dr Hill joined the Diamantina Institute with an NHMRC Career Development Award to initiate studies on the molecular links between obesity and cancer. She also received a PCFA grant to perform systems biology analysis in prostate cancer cell models.